Stocks · News reference
Ingredion Announces Tate & Lyle Stockholders Approve All-Cash Offer To Be Acquired By Ingredion For £5.95/Share
Ingredion Incorporated (NYSE: INGR) ("Ingredion"), a leading global provider of ingredient solutions for food, beverage, pharmaceutical, personal care, and industrial applications, confirms that shareholders of
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 28, 2026, 8:35 PM
- Checked
- Jul 28, 2026, 8:35 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Ingredion Incorporated 公佈 2026 年第二季度業績
Ingredion Incorporated reported Q2 2026 results with reported diluted EPS of $1.78 and adjusted EPS of $2.82, down from $2.99 and $2.87 respectively in Q2 2025. Net sales increased 1% to $1.85 billion, while adjusted operating income declined 5%. The company completed the sale of its Pakistan business majority stake and announced that Tate & Lyle shareholders approved its 595 pence all-cash acquisition offer. Ingredion reaffirmed full-year 2026 guidance with reported EPS of $9.15-$9.75 and adjusted EPS of $10.30-$10.90.
Read original at globenewswire-incIngredion Incorporated 公布 2026 年第二季度业绩
Ingredion Incorporated reported Q2 2026 results with reported diluted EPS of $1.78 versus $2.99 in Q2 2025, representing a 40% decline. The company reaffirmed full-year 2026 guidance with adjusted EPS expected between $10.30-$10.90. Notably, Tate & Lyle shareholders approved Ingredion's £595 pence per share all-cash acquisition offer on July 28, 2026, marking a significant step toward completing the transaction.
Read original at globenewswire-incIngredion, 2026년 2분기 견조한 실적 발표
Ingredion Incorporated reported Q2 2026 results showing a 31% decline in reported operating income and 5% decline in adjusted operating income year-over-year, with diluted EPS of $1.78 (reported) and $2.82 (adjusted). The company successfully sold a majority stake in its Pakistan business and received shareholder approval from Tate & Lyle for its 595 pence all-cash acquisition offer. Despite operational challenges at the Argo plant, the Texture & Healthful Solutions segment showed nine consecutive quarters of net volume growth. Full-year 2026 guidance was maintained with expected reported EPS of $9.15-$9.75 and adjusted EPS of $10.30-$10.90.
Read original at globenewswire-inc